Gujarat Themis Biosyn Ltd

NSE: GUJTHEM · BSE: 506879 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹417.00
Market cap: ₹5,427 Cr
Revenue (annual): ₹165.8 Cr
Net profit (annual): ₹46.68 Cr
P/E (TTM): 111.5×Sector 50.4×
Promoter holding: 59.33%-11.53% QoQ
FII holding: 4.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Debt & Borrowing 2 Annual General Meeting 2 Acquisition 2 Other Announcement 1 Dividend 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

16 Sep 2026 20:05 IST BSE

Debt & Borrowing

Gujarat Themis Biosyn Debt & Borrowing

Gujarat Themis Biosyn Limited announced the allotment of non-convertible debt securities. The filing serves as a regulatory disclosure regarding the issuance of these instruments.

Read the filing ↗

10 Sep 2026 19:37 IST BSE

Debt & Borrowing

Gujarat Themis Biosyn Debt & Borrowing: ₹585 Cr

The board of Gujarat Themis Biosyn approved the issuance of Non-Convertible Debentures (NCDs) aggregating up to ₹585 Crore on a private placement basis.

Value: ₹585.0 Cr

Read the filing ↗